This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Andrea Lenzi: Innovator in Erectile Dysfunction Treatment
Introduction
Andrea Lenzi is a notable inventor based in Rome, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of erectile dysfunction. His innovative approach combines various compounds to enhance therapeutic outcomes for patients.
Latest Patents
Andrea Lenzi holds a patent for the "Use of alkanoyl L-carnitine for the treatment of erectile dysfunction." This patent outlines a method for treating erectile dysfunction using a combination of propionyl L-carnitine along with sildenafil, apomorphine, prostaglandin E1, pentolamine, and papaverine. This innovative treatment approach aims to improve the quality of life for individuals affected by this condition.
Career Highlights
Lenzi is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., a company known for its commitment to pharmaceutical advancements. His work at Sigma-Tau has allowed him to focus on developing effective treatments that address critical health issues.
Collaborations
Andrea Lenzi collaborates with Aleardo Koverech, a talented woman in the field. Their partnership exemplifies the importance of teamwork in driving innovation and improving patient care.
Conclusion
Andrea Lenzi's contributions to the treatment of erectile dysfunction through his patented methods highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile